MUTANTS OF EMMONSIA CRESCENS - THEIR PATHOGENICITY AND SIZE OF ADIASPORES IN VIVO.HEJTMANEK M; BARTEK J.1976; FOLIA MICROBIOL.; TCHECOSL.; DA. 1976; VOL. 21; NO 4; PP. 297-300; BIBL. 11 REF.Article

VEGETATIVE PROPAGATION OF THE CACTUS MAMILLARIA WOODSII CRAIG THROUGH TISSUE CULTURES = PROPAGATION VEGETATIVE PAR CULTURE DE TISSUS DU CACTUS M. W. CRAIGKOLAR Z; BARTEK J; VYSKOT B et al.1976; EXPERIENTIA; SUISSE; DA. 1976; VOL. 32; NO 5; PP. 668-669; BIBL. 6REF.Article

Endoscopic assisted posterior decompression for spinal neoplasmsMOBBS, Ralph J; NAKAJL, Peter; SZKANDERA, Bartek J et al.Journal of clinical neuroscience. 2002, Vol 9, Num 4, pp 437-439, issn 0967-5868Article

PRODUCTION AND CHARACTERIZATION OF A MONOCLONAL ANTITUBULIN ANTIBODYVIKLICKY V; DRABER P; HASEK J et al.1982; CELL BIOL. INT. REP.; ISSN 0309-1651; GBR; DA. 1982; VOL. 6; NO 8; PP. 725-731; BIBL. 12 REF.Article

Distinct forms of human CDC2 identified by novel monoclonal antibodiesLUKAS, J; DRAETTA, G; BARTEK, J et al.European journal of biochemistry (Print). 1992, Vol 207, Num 1, pp 169-176, issn 0014-2956Article

Phylogenetically more conservative epitopes among monoclonal antibody-defined antigenic sites of human transferrin are involved in receptor bindingBARTEK, J; VIKLICKY, V; STRATIL, A et al.British journal of haematology. 1985, Vol 59, Num 3, pp 435-441, issn 0007-1048Article

Ubiquitin/proteasome-mediated degradation of p19^INK4d determines its periodic expression during the cell cycleTHULLBERG, M; BARTEK, J; LUKAS, J et al.Oncogene (Basingstoke). 2000, Vol 19, Num 24, pp 2870-2876, issn 0950-9232Article

Cell cycle-related variation and tissue-restricted expression of human cyclin D1 proteinBARTKOVA, J; LUKAS, J; STRAUSS, M et al.Journal of pathology. 1994, Vol 172, Num 3, pp 237-245, issn 0022-3417Article

The CHEK2 gene and inherited breast cancer susceptibilityNEVANLINNA, H; BARTEK, J.Oncogene (Basingstoke). 2006, Vol 25, Num 43, pp 5912-5919, issn 0950-9232, 8 p.Article

Cyclin D3 : requirement for G1/S transition and high abundance in quiescent tissues suggest a dual role in proliferation and differentiationBARTKOVA, J; LUKAS, J; STRAUSS, M et al.Oncogene (Basingstoke). 1998, Vol 17, Num 8, pp 1027-1037, issn 0950-9232Article

Expression of CDK7/CAK in normal and tumour cells of diverse histogenesis, cell-cycle position and differentiationBARTKOVA, J; ZEMANOVA, M; BARTEK, J et al.International journal of cancer. 1996, Vol 66, Num 6, pp 732-737, issn 0020-7136Article

Diversity of human p53 mutants revelaed by complex formation to SV40 T antigenBARTEK, J; VOJTESEK, B; LANE, D. P et al.European journal of cancer. Part A. 1993, Vol 29, Num 1, pp 101-107Article

Abundance and subcellular localisation of cyclin D3 in human tumoursBARTKOVA, J; ZEMANOVA, M; BARTEK, J et al.International journal of cancer. 1996, Vol 65, Num 3, pp 323-327, issn 0020-7136Article

Efficient transfer of antibodies into mammalian cells by electroporationLUKAS, J; BARTEK, J; STRAUSS, M et al.Journal of immunological methods. 1994, Vol 170, Num 2, pp 255-259, issn 0022-1759Article

p21^WAF1/CIP1 mutants deficient in inhibiting cyclin-dependent kinases (CDKs) can promote assembly of active cyclin D/CDK4(6) complexes in human tumor cellsWELCKER, M; LUKAS, J; STRAUSS, M et al.Cancer research (Baltimore). 1998, Vol 58, Num 22, pp 5053-5056, issn 0008-5472Article

Thoracoscopic retrieval of foreign bodies after penetrating chest traumaBARTEK, J. P; GRASCH, A; HAZELRIGG, S. R et al.The Annals of thoracic surgery. 1997, Vol 63, Num 6, pp 1783-1785, issn 0003-4975Article

The PRAD-1/cyclin D1 oncogene product accumulates aberrantly in a subset of colorectal carcinomasBARTKOVA, J; LUKAS, J; STRAUSS, M et al.International journal of cancer. 1994, Vol 58, Num 4, pp 568-573, issn 0020-7136Article

Keratin 19 expression in the adult and developing human mammary glandBARTEK, J; BARTKOVA, J; TAYLOR-PAPADIMITRIOU, J et al.Histochemical journal. 1990, Vol 22, Num 10, pp 537-544, issn 0018-2214, 8 p.Article

Overabundant FANCD2, alone and combined with NQO1, is a sensitive marker of adverse prognosis in breast cancerFAGERHOLM, R; SPROTT, K; HEIKKINEN, T et al.Annals of oncology. 2013, Vol 24, Num 11, pp 2780-2785, issn 0923-7534, 6 p.Article

Differences in phenotype and disease course in adult and paediatric inflammatory bowel disease - a population-based studyJAKOBSEN, C; BARTEK, J; WEWER, V et al.Alimentary pharmacology & therapeutics. 2011, Vol 34, Num 10, pp 1217-1224, issn 0269-2813, 8 p.Article

Centrosome abnormalities are frequently observed in non-small-cell lung cancer and are associated with aneuploidy and cyclin E overexpressionKOUTSAMI, M. K; TSANTOULIS, P. K; BARTEK, J et al.Journal of pathology. 2006, Vol 209, Num 4, pp 512-521, issn 0022-3417, 10 p.Article

Evolution of shape complementarity and catalytic efficiency from a primordial antibody templateJIAN XU; QIAOLIN DANG; JIANGANG CHEN et al.Science (Washington, D.C.). 1999, Vol 286, Num 5448, pp 2345-2348, issn 0036-8075Article

Potential role for concurrent abnormalities of the cyclin D1, p16^CDKN2 and p15^CDKN2B genes in certain B cell non-Hodgkin's lymphomas. Functional studies in a cell line (Granta 519)JADAYEL, D. M; LUKAS, J; CATOVSKY, D et al.Leukemia. 1997, Vol 11, Num 1, pp 64-72, issn 0887-6924Article

Expression of integrin subunits in the human infant breast correlates with morphogenesis and differentiationRAMASWAMY ANBAZHAGAN; BARTEK, J; STAMP, G et al.Journal of pathology. 1995, Vol 176, Num 3, pp 227-232, issn 0022-3417Article

Amplification and overexpression of cyclin D1 in breast cancer detected by immunohistochemical stainingGILLETT, C; FANTL, V; SMITH, R et al.Cancer research (Baltimore). 1994, Vol 54, Num 7, pp 1812-1817, issn 0008-5472Article